9 March 2021
Continuing our successful online discussions on key access to medicines (A2M) priorities bringing together thought leaders and policy-makers, academics, industry representatives and NGOs, for a frank discussion of European pharmaceutical policies.
Take part in our #A2MDialogues to share your questions and ideas and help us develop actionable #A2Msolutions for decision-makers in Europe.
A one-on-one interview with Professor Guido Rasi, former Executive Director, European Medicines Agency (EMA).
Professor Rasi will talk about about his time at the helm of Europe’s top regulator; the power balance between pharma and governments; the impact of the pandemic on the pharmaceutical regulatory framework and the innovation landscape and trends in Europe and beyond.
Professor Guido Rasi
Former Executive Director
European Medicines Agency
Policy Manager, Universal Access to Affordable Medicines
European Public Health Alliance
Catch up on EPHA’s other #A2MDialogues below
Getting it right: Recommendations for a European BARDA
8 December 2020
The Presidencies’ perspective on the pharmaceutical strategy: Europe’s to-do list on access to medicines
25 November 2020
Pharma & COVID19: Winners, losers, prospects
19 November 2020
The EU's IP strategy: Enabler or barrier?
27 October 2020
Unleashing meaningful innovation through regulatory reform
19 October 2020